MET-4
Sponsors
University Health Network, Toronto, Canadian Cancer Trials Group
Conditions
Advanced Head and Neck Squamous Cell CarcinomaAll Solid TumorsHead and Neck Squamous Cell Carcinoma
Phase 2
Feasibility Study of MET-4: Evaluating Fecal Microbiome Effects in Immunotherapy Patients
Active, not recruitingNCT03686202
Start: 2018-11-30End: 2026-12-01Target: 65Updated: 2026-02-09
PembROlizumab With or Without Microbial EcOsystem ThErapeutic 4 (MET4) in Advanced Head and Neck Squamous Cell Carcinoma
WithdrawnNCT05743777
Start: 2023-05-12End: 2023-05-12Updated: 2023-05-18